Dr. Bosch presented an abstract detailing comprehensive and broad t-cell response to DCVax-l in Vivo (formalizing part of his June 2023 ASCO presentation).
NWBO filed three (on time) 10Qs in a row (most recent one in November 2023) with no intervening filings.
The nuisance suit against NWBO will likely/hopefully be dismissed this month according to a few that follow it.
Defendant’s/Citadel’s (et al) MTD against plaintiff’s/NWBO’s lawsuit completed oral arguments today, and that should/hopefully result in a procedural win for NWBO before year’s end.
The MAA is to be submitted this month according to both a PR and a later 10Q filed by NWBO. This should allow a regulatory decision on acceptance before the Christmas holidays.
LL is on the SAB as of two months ago. This should allow her expertise to influence future combo trial designs, and of course, help with the post maa submission process.
Outstanding warrants seem predominantly exercised other than insiders that are blocked.
Market Data 
Markets 
AI
